Nemes Rush Group’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14K | Sell |
250
-50
| -17% | -$229 | ﹤0.01% | 639 |
|
|
2025
Q1 | $888 | Hold |
300
| – | – | ﹤0.01% | 649 |
|
|
2024
Q4 | $2.57K | Hold |
300
| – | – | ﹤0.01% | 592 |
|
|
2024
Q3 | $13.4K | Hold |
300
| – | – | ﹤0.01% | 377 |
|
|
2024
Q2 | $6.84K | Hold |
300
| – | – | ﹤0.01% | 444 |
|
|
2024
Q1 | $13.4K | Hold |
300
| – | – | ﹤0.01% | 412 |
|
|
2023
Q4 | $18.8K | Hold |
300
| – | – | ﹤0.01% | 352 |
|
|
2023
Q3 | $21.8K | Hold |
300
| – | – | ﹤0.01% | 331 |
|
|
2023
Q2 | $19.1K | Buy |
+300
| New | +$19.1K | ﹤0.01% | 368 |
|